Selecta Biosciences
Pioneering RNA cell therapy for autoimmune disease.
Launch date
Employees
Market cap
€326m
Enterprise valuation
€131m (Public information from Sep 2024)
Share price
$16.54 SELB
Watertown Massachusetts (HQ)
Authorizing premium user...